NCT00375180

Brief Summary

The investigators hope to learn more about how side-effects of RT or RTchemo affect food intake and nutrition status.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2006

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 11, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 12, 2006

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2006

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2012

Completed
Last Updated

February 25, 2016

Status Verified

March 1, 2012

Enrollment Period

5.2 years

First QC Date

September 11, 2006

Last Update Submit

February 24, 2016

Conditions

Head and Neck Cancer

Keywords

fooddietmucositisxerostomiadysphagiatastesmellhead and neckradiationchemotherapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Diagnosed with head and neck cancer including the lip, oral cavity, salivary glands, paranasal sinuses, oropharynx, nasopharynx, hypopharynx, larynx, and thyroid

You may qualify if:

  • years or older
  • Diagnosed with head and neck cancer including the lip, oral cavity, salivary glands, paranasal sinuses, oropharynx, nasopharynx, hypopharynx, larynx, and thyroid
  • All histological types of cancer
  • All tumour stages according to American Joint Committee for Cancer (AJCC) Staging
  • All forms of RT including standard or investigational and/or concurrent standard or investigational chemotherapy for head and neck cancers
  • Alert and mentally competent
  • English speaking

You may not qualify if:

  • Unwilling to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cross Cancer Institute

Edmonton, Alberta, T6G 1Z2, Canada

Location

MeSH Terms

Conditions

Head and Neck NeoplasmsMucositisXerostomiaDeglutition DisordersAnosmia

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsGastroenteritisGastrointestinal DiseasesDigestive System DiseasesMouth DiseasesStomatognathic DiseasesSalivary Gland DiseasesEsophageal DiseasesPharyngeal DiseasesOtorhinolaryngologic DiseasesOlfaction DisordersSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Vickie Baracos, MD

    AHS Cancer Control Alberta

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 11, 2006

First Posted

September 12, 2006

Study Start

November 1, 2006

Primary Completion

January 1, 2012

Study Completion

January 1, 2012

Last Updated

February 25, 2016

Record last verified: 2012-03

Locations

CA(1)